Paradigm reposted this
Paradigm is pleased to announce the results of our work with Highlands Oncology Group, which has achieved a remarkable 45% increase in patients enrolled in trials using our platform. Paradigm is also bringing new phase I - III interventional therapeutic clinical trial opportunities from biopharma sponsors tailored to Highlands’ local patient population and capabilities, increasing patient access to cutting edge therapy options. Read more in our case study, published today: https://lnkd.in/gNfrYJna Thank you to Highlands for trusting us with this important work, and congratulations on increasing access to high quality care for your patients.